{
  "nct_id": "NCT62919485",
  "indication": "Melanoma",
  "phase": "Phase 1",
  "sample_size": 67,
  "duration_weeks": 5,
  "dropout_rate": 0.02,
  "blinding": "single-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Objective response rate"
  ],
  "secondary_endpoints": [
    "Progression-free survival"
  ],
  "outcome_summary": "Primary endpoint met with statistical significance (p<0.05)",
  "success": 1,
  "start_date": "2022-06-04",
  "completion_date": "2022-07-09"
}